BRIDGEWATER, N.J. — Amneal Pharmaceuticals has appointed Rochelle Fuhrmann as CFO, the generic drug maker said Thursday.
Fuhrmann was formerly SVP finance at Warner Chilcott, where she was responsible for the oversight and direction of the finance and accounting functions, including corporate accounting, financial planning and analysis, tax, treasury, risk management, internal audit and investor relations. She began working at Warner Chilcott in June 2006 and was promoted to SVP in January 2011.
"Rochelle's strong leadership abilities, robust financial background and broad industry experience bring tremendous value to Amneal as well expand our global reach in both generic and specialty pharmaceuticals," Amneal chairman and co-CEO Chirag Patel said. "We welcome her strategic vision and proactive approach and are delighted that she has joined the Amneal family."